Commercial Use of Biodiversity

Commercial Use of Biodiversity

Access to Genetic Resources and Benefit-Sharing

Laird, Sarah A; Kate, Kerry Ten

Taylor & Francis Ltd

04/2021

418

Mole

Inglês

9780367357641

15 a 20 dias

793

Descrição não disponível.
List of Boxes, Figures and Tables Acronyms and Abbreviations Foreword Acknowledgments 1. Introduction 2. Regulation Access to Genetic Resources and Benefit-Sharing: The Legal Aspects 3. Natural Products and the Pharmaceutical Industry 4. The Botanical Medicine Industry 5. The Development of Major Crops by the Seed Industry 6. Horticulture 7. Crop Protection 8. Biotechnology in Fields Other Than the Healthcare and Agriculture 9. The Natural Personal Care and Cosmetics Industry 10. Industry and the CBD 11. Conclusions 12. Recommendations Appendix A: The Influence of Natural Products on 1997 Pharmaceutical Sales Figures Appendix B: Scientific and Common Names of Selected Botanical Medicines Appendix C: Regulatory Frameworks for Botanical Medicines Appendix D: Tentative List of Crops Under Negotiation as the Scope of the Multilateral System in the Revised International Undertaking Appendix E: Regulatory Frameworks Relevant to the Release of Crop Varieties Useful Contacts and Sources of Information Glossary Bibliography Research Methodology and Team Index
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Genetic Resources;High Throughput Screening;Biodiversity;Natural Products Researchers;Commerical Biodiversity;Access Legislation;Source Country Institutions;Benefit-Sharing;Crop Protection Products;Biological Ecology;Natural Products Research;Biology;Benefit Sharing Arrangement;Biological Diversity;Pic;Pharmaceutical Industry Investment;Crop Protection Industries;Ecology;Crop Protection;Ecosystems;Novo Nordisk;Environmental Change;Botanical Medicines;Natural Products;Crop Protection Companies;Private Sector;Plant Genetic Resources;Public Sector;St John's Wort;CBD;National Access Legislation;Natural Product Derived-Drugs;Benefit Sharing Agreements;Drug Discovery;Natural Product Sample;Pharmaceutical Drug Discovery;Prunus Africana;Natural Product Samples;Natural Personal Care;Ethnobotanics;Natural Product Drug Discovery;Geographic Diversity;Marine Genetic Resources;Botanical Medicine Industry;Biocontrol Agents;Botanical Medicine Products;Ornamental Varieties;Major Crops;Seed Industry;Ethnobotanic Drug Discovery;GMOs;Agricultural Crop Varieties;Seed Breeding;Exotic Material Crop Breeding;Exotic Materials;Crop Breeding;Horticulture;Biotechnology;Biotechnology in Agriculture;Agriculture;Diversa/INbio Agreement;Cosmetics Industry;Cosmetics Market;Impact Demand for Natural Products;Ingredient Trends;Raw Materials;Regulatory Environment;'New Species';Guatemala;Yawanawa and Aveda Corporation;Cohune Oil;Conservational International;Environmental Issues;Social Issues;Corporate Policies;Legal Policy Environment;commercialisation;Convention on Biodiversity;sector-by-sector analysis;national laws